HealthData.Gov
Serial counts of
Background Since the sterilising activity of new antituberculosis drugs is difficult to assess by conventional phase III studies, surrogate methods related to eventual relapse rates are required. Methods A suitable…
- HTML
Updated Oct 29, 2026